Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,544,182
-
Total 13F shares
-
25,458,553
-
Share change
-
+25,458,553
-
Total reported value
-
$701,864,000
-
Price per share
-
$28.26
-
Number of holders
-
52
-
Value change
-
+$701,864,000
-
Number of buys
-
52
Institutional Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q2 2020
As of 30 Jun 2020,
Avidity Biosciences, Inc. - Common Stock (RNA) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,458,553 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, FMR LLC, Cormorant Asset Management, LP, EcoR1 Capital, LLC, PERCEPTIVE ADVISORS LLC, Matrix Capital Management Company, LP, BOXER CAPITAL, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Logos Global Management LP, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.